Compounds > 1-ethyl-3-(3-dimethylaminoethyl)carbodiimide
Page last updated: 2024-09-03

1-ethyl-3-(3-dimethylaminoethyl)carbodiimide and chondroitin sulfates

1-ethyl-3-(3-dimethylaminoethyl)carbodiimide has been researched along with chondroitin sulfates in 5 studies

Compound Research Comparison

Studies
(1-ethyl-3-(3-dimethylaminoethyl)carbodiimide)		Trials
(1-ethyl-3-(3-dimethylaminoethyl)carbodiimide)		Recent Studies (post-2010)
(1-ethyl-3-(3-dimethylaminoethyl)carbodiimide)		Studies
(chondroitin sulfates)		Trials
(chondroitin sulfates)		Recent Studies (post-2010) (chondroitin sulfates)
680107,8813152,337

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grant, MH; Hanthamrongwit, M; Reid, WH1
Grant, MH; Osborne, CS; Reid, WH1
Li, S; Parrish, RS; Pumphrey, CY; Sanderson, RD; Theus, AM1
Grant, H; Henderson, C; Kataropoulou, M1
Chiu, CC; Lin, YT; Sun, SL; Sung, KH; Wang, LF1

Other Studies

5 other study(ies) available for 1-ethyl-3-(3-dimethylaminoethyl)carbodiimide and chondroitin sulfates

ArticleYear
Chondroitin-6-sulphate incorporated into collagen gels for the growth of human keratinocytes: the effect of cross-linking agents and diamines.
    Biomaterials, 1996, Volume: 17, Issue:8

    Topics: Analysis of Variance; Carbodiimides; Cell Division; Cells, Cultured; Chondroitin Sulfates; Collagen; Cross-Linking Reagents; Drug Carriers; Gels; Glycosaminoglycans; Hexanes; Humans; Hyaluronic Acid; Keratinocytes; Putrescine; Skin, Artificial; Urea

1996
Investigation into the biological stability of collagen/chondroitin-6-sulphate gels and their contraction by fibroblasts and keratinocytes: the effect of crosslinking agents and diamines.
    Biomaterials, 1999, Volume: 20, Issue:3

    Topics: Biocompatible Materials; Carbodiimides; Cells, Cultured; Chondroitin Sulfates; Collagen; Cross-Linking Reagents; Drug Stability; Fibroblasts; Gels; Humans; Imidazoles; Keratinocytes; Skin, Artificial

1999
Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis.
    Cancer research, 2002, Jul-01, Volume: 62, Issue:13

    Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carbodiimides; Cell Division; Cell Survival; CHO Cells; Chondroitin Sulfates; Cricetinae; Dogs; Drug Screening Assays, Antitumor; Female; Glycosaminoglycans; Heparin; Humans; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Multiple Myeloma; Proteoglycans; Syndecan-1; Syndecans; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2002
The influence of glycosaminoglycans and crosslinking agents on the phenotype of hepatocytes cultured on collagen gels.
    Human & experimental toxicology, 2003, Volume: 22, Issue:2

    Topics: Animals; Carbodiimides; Cell Culture Techniques; Cell Survival; Cells, Cultured; Chondroitin Sulfates; Collagen; Cross-Linking Reagents; Culture Media; Cytochrome P-450 Enzyme System; Diamines; Drug Combinations; Gels; Glutathione Transferase; Hepatocytes; Male; Phenotype; Rats; Rats, Sprague-Dawley

2003
Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex.
    Journal of biomaterials science. Polymer edition, 2011, Volume: 22, Issue:11

    Topics: Antineoplastic Agents; Carbodiimides; Cell Survival; Chondroitin Sulfates; Doxorubicin; Drug Carriers; Endocytosis; Folic Acid; Folic Acid Transporters; Humans; KB Cells; Polyethylene Glycols

2011